SHAREHOLDER ALERT: Pomerantz Regulation Agency Investigates Claims On Behalf of Traders of Bayer Aktiengesellschaft

0
4
Greenberg Traurig Expands Real Estate Practice in Los Angeles, Adds Michael Seiden

<p class = "Artboard-Atom Artboard-Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "NEW YORK, NY / ACCESSWIRE / August 1, 2020 / Pomerantz LLP investigates claims on behalf of investors from Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC PINK: BAYRY). These investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, extension 7980. "data-reactid =" 12 ">NEW YORK, NY / ACCESSWIRE / August 1, 2020 / Pomerantz LLP investigates claims on behalf of investors from Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC PINK: BAYRY). These investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 1. 7980.

The investigation concerns whether Bayer and some of its officers and / or directors have committed securities fraud or other unlawful business practices.

<p class = "Artboard-Atom Artboard-Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "(Click here for information on participating in the class action lawsuit.)"data-reactid =" 14 "> (Click here for information on joining the class action lawsuit.)

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "On August 10, 2018 a jury was in the action Johnson vs. Monsanto Co.CGC-16-550128 (Cal. Super. Ct., Cnty. Of S.F.) (the "Johnson Case ") unanimously stated that the glyphosate-based Roundup weekly killer manufactured by the Bayer subsidiary Monsanto Company (" Monsanto ") was an" essential factor "for the plaintiff's development of Non-Hodgkin's lymphoma and that Monsanto knew or should have known, The jury also determined that Monsanto was acting with "malice or oppression" and should be punished for its conduct, and the jury asked Monsanto to pay $ 39 million in damages and $ 250 million in punitive damages. In the news, Bayer ADRs fell $ 3.00 per ADR or 11.28% to $ 23.59 per ADR. "Data-reactid =" 19 "> On August 10, 2018, a jury appealed to the suit Johnson v. Monsanto Co., No. CGC-16-550128 (Cal. Super. Ct., Cnty. Of SF) (the "Johnson Fall") unanimously stated that that of Bayer subsidiary Monsanto Company ("Monsanto" ) produced Roundup weekly killer based on glyphosate an "essential licher factor "for the development of non-Hodgkin's lymphoma by the plaintiff and that Monsanto knew or should have known the risks associated with exposure to the chemical and did not warn of this serious health risk. The jury also found that Monsanto was acting with "malice or oppression" and should be punished for his behavior. The jury accordingly requested Monsanto to pay $ 39 million in damages and $ 250 million in punitive damages. In the news, Bayer ADRs fell $ 3.00 per ADR or 11.28% to close at $ 23.59 per ADR.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Then, on October 22, 2018, although the court in of the Johnson The case reduced the award of punitive damages from $ 250 million to $ 39 million to match the claimant's damages. Despite the judgment and Monsanto's request for a new trial, the court rejected Monsanto's motion for judgment and upheld the jury's verdict "There is no legal basis to upset the jury's finding that the plaintiff's exposure to (glyphosate-based herbicides) is a significant factor for the development of his (non-Hodgkin's lymphoma). " In the news, Bayer ADRs fell $ 1.90 per ADR or 8.64% and closed at $ 20.10 per ADR. "Data-reactid =" 20 "> Then, on October 22, 2018, although the court had reduced Johnson's case. The court rejected Monsanto's motion for judgment despite the judgment and Monsanto's motion for a new trial, and upheld the jury's verdict by stated that "there" is not a legal basis to upset the jury's finding that the plaintiff's exposure to (glyphosate-based herbicides) was a major factor in his (non-Hodgkin's lymphoma). "In these news, the price dropped for Bayer UAW by $ 1.90 per ADR or 8.64% to close at $ 20.10 per ADR.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Finally on March 19, 2019 a jury in action Hardeman vs. Monsanto Co., No. 3: 16-cv-525 (ND Cal.) – the first federal Roundup cancer lawsuit to be brought to trial – passed a judgment on the cause of the damage in phase one of the forked trial, noting that the "exposure of the Plaintiff versus Roundup was significant. " Factor in causing his non-Hodgkin's lymphoma. "In the news, Bayer ADRs fell $ 1.82 per ADR or 9.25% to close at $ 17.85 per ADR." Data-reactid = "21"> On March 19, 2019, one finally closed Jury in the Hardeman v. Monsanto Co., No. 3: 16-cv-525 (ND Cal.) – the first federal Roundup cancer lawsuit to be brought to trial – ruled on the cause of the damage in phase 1 of the forked trial, noting that the Plaintiff's exposure to Roundup was a key factor in the development of his non-Hodgkin's lymphoma. "In the news, Bayer UAW prices fell $ 1.82 per ADR, or 9.25%, to close at $ 17.85 per ADR.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "The company Pomerantz with offices in New York, Chicago, Los Angeles and Paris are considered to be one of the leading law firms in corporate, securities and antitrust litigation, founded by the late Abraham L. Pomerantz, known as dean of the class action lawsuit, the Pomerantz Firm pioneering class action lawsuits against securities. Today, more More than 80 years later, Pomerantz continues its tradition of fighting for victims of securities fraud, fiduciary violations and corporate misconduct, and has recovered numerous million dollar damages on behalf of class members www.pomerantzlaw.com. "data-reactid =" 22 "> Pomerantz, with offices in New York, Chicago, Los Angeles and Paris, is one of the leading companies in corporate, securities and antitrust litigation. Founded by the late Abraham L. Pomerantz, Known as the dean of the class action lawsuit, was a pioneer of the Pomerantz company and today, more than 80 years later, the Pomerantz company continues its tradition of fighting for the rights of victims of securities fraud, breaches of trust and misconduct by companies has claimed back several million dollars in damages on behalf of class members, see www.pomerantzlaw.com.

<p class = "Artboard-Atom Artboard-Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "SOURCE: Pomerantz LLP "data-reactid =" 23 ">SOURCE: Pomerantz LLP

View source version at accesswire.com:
https://www.accesswire.com/599973/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Bayer-Aktiengesellschaft–BAYRY

LEAVE A REPLY

Please enter your comment!
Please enter your name here